Mode
Text Size
Log in / Sign up
N/A Completed N=63 Randomized Quadruple-blind Treatment

Treatment of Androgenetic Alopecia in Females, 12 Beam

androgenetic alopecia · Hair Loss · Female Pattern Baldness
Source: ClinicalTrials.gov NCT01016964 ↗
Enrolled (actual)
63
Serious AEs
0.0%
Results posted
Sep 2012
Primary outcomePrimary: Change in Hair Count at 16 and 26 Weeks Over Baseline — -0.8; 12.5; 3.0; 20.6 hairs per cm^2

Summary

The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 12 beam model for androgenetic alopecia in females when treatment is applied as directed.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Hair Count at 16 and 26 Weeks Over Baseline
-0.8; 12.5; 3.0; 20.6

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of androgenetic alopecia
  • Fitzpatrick Skin types I-IV
  • Ludwig I-4, II-1, II-2, or frontal
  • Active hair loss within last 12 months

Exclusion Criteria

  • Photosensitivity to laser light
  • Malignancy in the target area
  • Pregnancy
  • Lactating females
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01016964). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search